Sökning: WFRF:(Tiainen Marjaana) >
The predictive valu...
The predictive value of soluble urokinase plasminogen activator receptor (SuPAR) regarding 90-day mortality and 12-month neurological outcome in critically ill patients after out-of-hospital cardiac arrest. Data from the prospective FINNRESUSCI study
-
Jalkanen, Ville (författare)
-
Vaahersalo, Jukka (författare)
-
Pettila, Ville (författare)
-
visa fler...
-
Kurola, Jouni (författare)
-
Varpula, Tero (författare)
-
Tiainen, Marjaana (författare)
-
Huhtala, Heini (författare)
-
Alaspaa, Ari (författare)
-
Hovilehto, Seppo (författare)
-
Kiviniemi, Outi (författare)
-
Kuitunen, Anne (författare)
-
- Tenhunen, Jyrki (författare)
- Uppsala universitet,Anestesiologi och intensivvård
-
visa färre...
-
(creator_code:org_t)
- Elsevier BV, 2014
- 2014
- Engelska.
-
Ingår i: Resuscitation. - : Elsevier BV. - 0300-9572 .- 1873-1570. ; 85:11, s. 1562-1567
- Relaterad länk:
-
https://urn.kb.se/re...
-
visa fler...
-
https://doi.org/10.1...
-
visa färre...
Abstract
Ämnesord
Stäng
- Aim: The whole body ischaemia-reperfusion after cardiac arrest (CA) induces a systemic inflammation-reperfusion response. The expression of urokinase plasminogen activator receptor (uPAR) is known to be induced after hypoxia and increased levels of soluble form suPAR have been measured after hypoxia and ischaemia. Our aim was to evaluate, whether ischaemia/reperfusion injury after out-of-hospital cardiac arrest (OHCA) increases suPAR concentrations in serum and to evaluate the prognostic value of suPAR regarding 90-day mortality and 12-month neurological outcome. Methods: This is a pre-determined substudy of prospective FINNRESUSCI study. Total of 287 patients treated in the intensive care units after OHCA and with consent from the next-of-kin and serum samples between baseline and day 4 were included. Outcome and neurological outcome were evaluated according the Pittsburgh Cerebral Performance Categories (CPC). Kaplan-Meier survival curves, areas under receiver operational characteristics curves and positive likelihood ratios for mortality and poor neurological outcome were calculated. Results: Non-survivors had higher levels of suPAR after OHCA. Kaplan-Meier survival curves indicated high 90-day mortality in the highest concentration quintiles. LR+ for 1-year CPC 3-5 was 1.8-2.7 for the whole patient cohort and in shockable rhythms 2.0-2.4. In therapeutic hypothermia prognostic value remained. Conclusions: We found that high SuPAR concentrations were associated with poor outcome in patients with OHCA admitted to critical care. However, suPAR alone had inadequate predictive value for poor outcome and did not associate with 12-month neurological outcome.
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Anestesi och intensivvård (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Anesthesiology and Intensive Care (hsv//eng)
Nyckelord
- Soluble urokinase plasminogen activator receptor (suPAR)
- Resuscitation
- Biomarkers
- OHCA
- Out-of-hospital cardiac arrest
- Prognostication after cardiac arrest
Publikations- och innehållstyp
- ref (ämneskategori)
- art (ämneskategori)
Hitta via bibliotek
Till lärosätets databas
- Av författaren/redakt...
-
Jalkanen, Ville
-
Vaahersalo, Jukk ...
-
Pettila, Ville
-
Kurola, Jouni
-
Varpula, Tero
-
Tiainen, Marjaan ...
-
visa fler...
-
Huhtala, Heini
-
Alaspaa, Ari
-
Hovilehto, Seppo
-
Kiviniemi, Outi
-
Kuitunen, Anne
-
Tenhunen, Jyrki
-
visa färre...
- Om ämnet
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Klinisk medicin
-
och Anestesi och int ...
- Artiklar i publikationen
-
Resuscitation
- Av lärosätet
-
Uppsala universitet